Clinical Trials Sponsored by Liuzhou Cancer Hospital

Total 10374 results

Zhejiang Cancer Hospital

Completed

The Role of Clean Intermittent Catheterization in Patients Undergoing Radiotherapy After Radical Hysterectomy for Cervical Cancer

Uterine Cervical Neoplasms

China
Hubei Cancer Hospital

Completed

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Nasopharyngeal Carcinoma

China
Hubei Cancer Hospital

Enrolling by invitation

Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC

NSCLC

China
Henan Cancer Hospital

Active, not recruiting

Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma

Gastric Cancer

China
Zhejiang Cancer Hospital

Active, not recruiting

Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Zhejiang Cancer Hospital

Completed

Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study

Breast Cancer | PI3K/AKT/mTOR Pathway Mutation | Everolimus

China
Zhejiang Cancer Hospital

Unknown

Rituximab Combined With Chidamide and Lenalidomide for r/r AITL (AITL)

Angioimmunoblastic T-cell Lymphoma | Chemotherapy Effect | Chemotherapeutic Toxicity

China
Fujian Cancer Hospital

Completed

PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain

Cancer Pain

China
Fujian Cancer Hospital

Withdrawn

Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer (SIRB2)

Metastatic Colorectal Cancer

China
Zhejiang Cancer Hospital

Unknown

A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer

Esophageal Cancer

China
Henan Cancer Hospital

Unknown

S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC

Advanced NSCLC With EGFR Mutation

China
Barretos Cancer Hospital

Completed

Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas

Kidney Cancer | Biomarkers | Gene Expression

Brazil
Henan Cancer Hospital

Terminated

Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer

Advanced Cancer

China
Zhejiang Cancer Hospital

Unknown

Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test (CMTNCMB)

Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer

China
Hunan Cancer Hospital

Unknown

PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage

Lymphoma

China
Henan Cancer Hospital

Unknown

SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer

Triple-negative Breast Cancer
Zhejiang Cancer Hospital

Unknown

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

China
Barretos Cancer Hospital

Unknown

Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional After Breast Cancer Surgery

Breast Cancer
Henan Cancer Hospital

Unknown

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Advanced Cancer | Mucosal Melanoma | Apatinib | SHR-1210

China
Henan Cancer Hospital

Unknown

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

Gastrointestinal Neuroendocrine Tumor
Henan Cancer Hospital

Unknown

Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer

Advanced Gastric Cancer
Zhejiang Cancer Hospital

Unknown

Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy (CALORIE)

Breast Cancer
Zhejiang Cancer Hospital

Unknown

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

Cancer Pain

China
Zhejiang Cancer Hospital

Unknown

Individualized Pharmaceutical-care for Inpatients With Cancer Pain

Cancer Pain

China
Zhejiang Cancer Hospital

Unknown

Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer

Breast Cancer
Zhejiang Cancer Hospital

Unknown

A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients

Malignant Neoplasm of Nasopharynx

China
Fujian Cancer Hospital

Unknown

Study of the Combination of Apatinib and POF

Gastric Adenocarcinoma

China
Zhejiang Cancer Hospital

Unknown

Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Fujian Cancer Hospital

Unknown

Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel

Non-squamous Non-small Cell Lung Cancer
Barretos Cancer Hospital

Unknown

Impact of AferBio® on Quality of Life and Chemotherapy Toxicity in Lung Cancer Patients (AFERBIO)

Quality of Life | Infection | Drug Toxicity

Brazil
Fujian Cancer Hospital

Unknown

Appaconitine Patch for Oral Mucositis Pain Caused by Chemoradiotherapy in Patients With Nasopharyngeal Cancer

Radiation Induced Oral Mucositis

China
Fujian Cancer Hospital

Unknown

Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation (Geber)

Lung Adenocarcinoma | EGFR Mutation

China
Henan Cancer Hospital

Unknown

The FLOT Regimen Conversion Therapy of Adenocarcinoma of the Stomach / Gastroesophageal

Adenocarcinoma of the Stomach / Gastroesophageal

China
Zhejiang Cancer Hospital

Unknown

Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer (ACCN)

Neoadjuvant Therapy

China
Fujian Cancer Hospital

Unknown

EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide

Chemotherapy Effect | NSCLC Stage IV

China
Zhejiang Cancer Hospital

Completed

DEB-TACE Treatment in 367 Liver Cancer Patients

Liver Cancer
Fujian Cancer Hospital

Unknown

Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment

SCLC
Zhejiang Cancer Hospital

Unknown

Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer

Cervical Cancer Stage IVB

China
Barretos Cancer Hospital

Completed

Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer (Swallowing-1)

Swallowing Disorders | Head Neck Cancer

Brazil
Zhejiang Cancer Hospital

Unknown

Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer

Breast Cancer

China
Fujian Cancer Hospital

Unknown

Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer

Advanced Gastric Cancer

China
Barretos Cancer Hospital

Terminated

A Psychosocial Intervention Plus Early Palliative Care in the Reduction of Depression of Advanced Cancer Patients (PREPArE)

Neoplasms

Brazil
Fujian Cancer Hospital

Unknown

Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction

China
Ningbo Cancer Hospital

Unknown

PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies

Advanced Cancer | Solid Tumor, Adult

China
Ningbo Cancer Hospital

Unknown

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Chemotherapy | Advanced Gastric Cancer | Precision Cell Immunotherapy

China
Fujian Cancer Hospital

Unknown

EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC (effect)

EGFR Gene Mutation
Hangzhou Cancer Hospital

Unknown

Apatinib for Metastatic Esophageal Cancer.

Esophageal Cancer | Apatinib | Metastatic Esophageal Cancer

China
Barretos Cancer Hospital

Unknown

The Use of Cap-assisted Forward Viewing Endoscopy for Examination of the Ampulla of Vater

Ampulla of Vater Intestinal-Type Adenoma

Brazil

3

Subscribe